Internal Medicine Alert - January 30, 2014

Target Audience:

This CME activity is intended for the internist/family physician.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This activity has been reviewed and is acceptable for up to 1.0 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/15/14. Term of approval is for one year from this date. Credit may be claimed for 1 year from the date of this issue.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Internal Medicine Alert has been reviewed and is acceptable for up to 1 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins 01/15/13. Term of approval is for one year from this date with the option of yearly renewal.

Faculty Listing:

Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Executive Editor
Leslie Coplin

Managing Editor
Neill Kimball

Associate Editors
Allan J. Wilke, MD
Professor and Chair
Program Director
Department of Family Medicine
Western Michigan University School of Medicine
Kalamazoo

William T. Elliott, MD, FACP
Chair, Formulary Committee,
Northern California Kaiser Permanente;
Assistant Professor of Medicine,
University of California, San Francisco.

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager,
Kaiser Permanente,
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida
Gainesville

Authors
Harold L. Karpman, MD, FACC, FACP
Clinical Professor of Medicine,
UCLA School of Medicine

Martin S. Lipsky, MD
Padmaja Kandula, MD
Assistant Professor of Neurology and Neuroscience,
Comprehensive Epilepsy Center,
Weill Cornell Medical College

Andrew Goldfine, MD
Assistant Professor of Neurology,
Weill Cornell Medical College

Claire Henchcliffe, MD
Associate Professor of Neurology and Neuroscience,
Weill Cornell Medical College

John C. Hobbins, MD
Professor,
Department of Obstetrics and Gynecology,
University of Colorado School of Medicine,
Aurora

Peer reviewer
Gerald Roberts, MD
Senior Attending Physician
Long Island Jewish Medical Center
NS/LIJ Health Care System
New Hyde Park, NY

Subjects:

  • What Is Our Current Understanding of Epilepsy Prognosis?
  • Sometimes Coma Is Not a Coma
  • Does Dietary Nicotine Protect Against Parkinson's Disease?
  • Alcohol in Pregnancy

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe the advantages, disadvantages and controversies surrounding the latest advances in the diagnosis and treatment of disease
  • Identify cost-effective treatment regimens
  • Explain the advantages and disadvantages of new disease screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton,MD, serves on the advisory board for Abbott, Amarin,Boehringer Ingelheim, Duchesnay, Janssen, Lilly,Novo Nordisk, Sunovion, and Teva; he serves on the speakers bureau of Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Peer reviewer Gerald Roberts, MD; executive editor Leslie Coplin; and managing editor Neill Kimball report no financial relationships relevant to this field of study.

Authos Padmaja Kandula, MD, Andrew Goldfine, MD, and John C. Hobbins, MD, William T. Elliott, MD, FACP, and James Chan, PharmD, PhD reports no financial relationships relevant to this field of study.

Author Claire Henchcliffe, MD reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmith- Kline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.

Louis Kuritzky, MD is a retained consultant for Boehringer Ingelheim, Daiichi Sankyo, Forest Pharmaceuticals, Janssen, Lilly, Novo Nordisk, Pfizer, and Sanofi.

Copyright 2014, AHC Media. All rights reserved.